GOOG (Alphabet Inc.) – Technical Analysis Report

Date of analysis: July 10, 2026 Current Price: $356.23 (close Jul 9, 2026) Context: GOOG pulled back sharply from its May 18 all-time high of $404.47 to a panic-sell low of $333.69 on June 26, and is now in a recovery phase. The stock remains a "Strong Buy" by 33 Wall Street analysts with an average 12-month target of $428 (+20%).


Indicators Selected (8) – Rationale for Mix

Given the pullback-within-uptrend context, I selected a complementary mix that captures (a) trend direction at three timeframes, (b) momentum shifts, (c) volatility boundaries, and (d) risk sizing. No redundant indicators were used.

# Indicator Category Why it's chosen for this market
1 close50sma Moving Averages The $369.63 zone is the line in the sand between bear (below) and bull (above) for the medium term.
2 close200sma Moving Averages $317.24 — the long-term uptrend benchmark; price sits +12% above it, confirming the secular bull is intact.
3 close10ema Moving Averages $357.09 — very short-term momentum; price is right at it, making it the immediate pivot.
4 macd MACD Captures whether the recovery can turn the zero-line (currently still negative at -1.96).
5 macd_hist MACD Six consecutive days of expanding positive bars (+1.56) show momentum rebuilding — critical for early reversal confirmation.
6 rsi Momentum Tagged 33.4 (oversold) on Jun 26 — a textbook bottom signal. Now 49.8 (neutral) = room to run before overbought.
7 boll_ub Volatility $374.29 is the next upside target and resistance zone from the upper Bollinger Band.
8 atr Volatility 14-day ATR of $10.89 (~3.1% of price) is essential for stop placement after the recent vol expansion.

Indicators intentionally omitted: close200sma redundancy with 50 SMA avoided; macdsignal subsumed into the macd+macdhist pairing; bolllb/bollmid redundant with 20 SMA and lower-band context already covered; vwma is short-term/intraday (limited value on daily swing context where the trend indicators dominate).


Key Data Extracted

Moving Averages (Jul 8/9, 2026):

MACD (Jul 8): MACD -1.96, Signal -3.52, Histogram +1.56 (bullish crossover confirmed on Jul 1; histogram has expanded for 6 straight sessions).

RSI (14): 49.79 (Jul 8). Range over the period: 33.39 → 61.55. Trough was the panic-low day.

Bollinger Bands (Jul 8): Upper 374.29, Middle 356.04, Lower 337.79. Bands have compressed from a $405 upper (Jun 4) to $374 — volatility is contracting.

ATR (14): 10.89 (down from 11.90 on Jun 22 selloff peak).

Volume: Bounce from $334 → $356 has been on declining volume (12.2–16.4M daily vs. 25M+ selloff volume) — recovery lacks high-conviction participation so far.

Key analyst data: 33 analysts, 28 Buy / 5 Hold / 0 Sell. Average target $428 (+20%). High $515, Low $349.94.


Nuanced Analysis & Actionable Insights

1. The Big Picture: Healthy Correction Inside a Powerful Uptrend

2. The 50 SMA = The Battle Line

3. Momentum: The "Early Innings" Bullish Crossover

4. Bollinger Bands: Volatility Compression = Coiled Spring

5. Volatility / Risk Management (ATR-based)

6. The Volume Caveat

7. Catalyst Calendar & Fundamental Tailwind


Summary Trade Framework

Scenario Trigger Target Stop
Bullish swing Close > $362 on volume ≥20M (or 10 EMA retest holds) $374 (BB upper) → $389 (50 SMA test) → $404 (ATH) $345 (1× ATR)
Neutral/base Price holds $355-$369 range Range-trade; sell $368 / buy $355 n/a
Bearish break Close < $345 with volume $338 (BB lower) → $317 (200 SMA) n/a (already stopped out)

Probabilities (subjective): Bullish swing 50% / Neutral 30% / Bearish break 20%, given the intact 200 SMA uptrend, improving MACD, and oversold-to-neutral RSI recovery. The path of least resistance, supported by fundamentals (28 of 33 analysts Strong Buy, $445 target), is up — but a trader should size positions for the 20% downside scenario given the proximity to the 50 SMA resistance and the unconfirmed volume on the bounce.

Best risk/reward: Long on a successful retest of the 10 EMA ($357) or 20 SMA ($355) as new support, with a tight $345 stop (~3.1% risk), targeting the 50 SMA at $369 first (R/R 1.5:1) and then the ATH retest (R/R 4.5:1).